CENTOGENE AG: CENTOGENE Launches Two Year Global Parkinson’s Disease Study

CENTOGENE AG: CENTOGENE Launches Two Year Global Parkinson’s Disease Study
One of the Largest, Most Ethnically Diverse Studies of Parkinson's Disease to Uncover the Genetic Basis of One of the Most Common Neurodegenerative Disorders CAMBRIDGE, MA and ROSTOCK, GERMANY / ... read more
Source: Bing NewsPublished on 2019-05-13